Author:
Juvet Tristan,Mari Andrea,Lajkosz Katherine,Wallis Christopher JD,Kuk Cynthia,Erlich Annette,Krimus Lior,Fleshner Neil E.,Kulkarni Girish S,Zlotta Alexandre R.
Reference24 articles.
1. Treatment strategy for newly diagnosed T1 high-grade bladder urothelial carcinoma: new insights and updated recommendations;Klaassen;Eur Urol,2018
2. FDA Draft Guidance. BCG-Unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment guidance for industry. Last accessed November 13, 2018. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM529600.pdf
3. Sequential intravesical gemcitabine and docetaxel for the salvage treatment of non-muscle invasive bladder cancer;Steinberg;Bladder Cancer,2015
4. Electromotive delivery of mitomycin C into human bladder wall;Di Stasi;Cancer Res,1997
5. Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial;Di Stasi;Lancet Oncol,2006
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献